Concepedia

Maria Milanova

MM

Statistics

Publications

6

Citations

1.5K

H-Index

6

Active since

2015

Affiliations

UNSW Sydney(Current)

Harvard University

Brigham and Women's Hospital

The George Institute for Global Health

AstraZeneca (Sweden)

Maria Milanova is an author at UNSW Sydney specializing in medicine, cardiovascular disease, and cardiology.

Publications per year

2015–2022

6

Publications

6

2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery

Sigrun Halvorsen, Julinda Mehilli, Salvatore Cassese et al. · European Heart Journal · 2022 · 1.1K citations · Full text

, , +11

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

, , +15

Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction

Burkert Pieske, Rolf Wachter, Sanjiv J. Shah et al. · JAMA · 2021 · 161 citations · Full text

, , +14

Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy

Kieran F. Docherty, Pardeep S. Jhund, Olof Bengtsson et al. · Diabetes Care · 2020 · 44 citations · Full text

, , +16

Blood pressure control predicts plasma matrix metalloproteinase-9 in diabetes mellitus type II

Katerina Vitlianova, Janeta Georgieva, Maria Milanova et al. · Archives of Medical Science · 2015 · 17 citations · Full text

, , +14

1–5 of 6